Unraveling the Dynamic Interplay of SARS-CoV-2 Neutralizing Monoclonal Antibodies and Host Immunity in Hospitalized Patients with COVID-19 2264
Year: 2025
Type: article
Abstract: Description Passive administration of SARS-CoV-2 neutralizing monoclonal antibodies, such as the CAS+IMD (REGEN-COV®, Ronapreve, REGN-COV2) antibody cocktail, benefits viral load, mortality rate, and clinical course in COVID-19 patients. However, their impact on resolving pathogenic inflammatory response and host immunity is less understood. This study examined CAS+IMD’s interaction with host immunity using longitudinal plasma proteomics and high-dimensional flow cytometry data. Unbiased clustering identified unique immunophenotypes linked to acute inflammation and disease resolution. Compared to the placebo group, CAS+IMD accelerated the shift from an acute inflammatory to a less inflammatory or “resolving” immunophenotype, marked by reduced tissue injury, lower proinflammatory markers, and restored lymphocyte/monocyte balance, regardless of baseline serostatus. Additionally, CAS+IMD did not impair the magnitude or quality of host T cell immunity against the SARS-CoV-2 spike protein. These findings suggest that SARS-CoV-2 neutralizing antibodies can rapidly resolve inflammatory responses, reducing the need for systemic steroids, without compromising cellular antiviral immunity. Funding Sources Supported Regeneron Pharmaceuticals and Department of Health and human service under OT number: HHSO100201700020C. Topic Categories Translational and Interventional Immunology (TI)
Source: The Journal of Immunology
Authors: Bei Wang, Jacquelynn Golubov, Patrick Poon, Qiaozhi Wei, Clarissa Lett, Fadi Shehadeh, Matthew Kaczynski, Lewis Oscar Felix, Biswajit Mishra, Evangelia K Mylona, Matthew F Wipperman, Erica Chio, Sara C Hamon, Andrea T Hooper, Selin Somersan-Karakaya, Bret J Musser, Christopher D Petro, Jennifer D Hamilton, Matthew A Sleeman, George D Kalliolias, Eleftherios Mylonakis, Dimitris Skokos
Language: English
Subfield: Infectious Diseases
Field: Medicine
Domain: Health Sciences
Open Access status: bronze
OpenAlex ID: W4416448652
FWCI:
Cites:
Cited by:
Related to: